Twitch response using accelerometry and plasma concentrations of vecuronium and its metabolite were studied in 27 surgical patients during xenon or sevoflurane anaesthesia after administration of vecuronium 0.05 mg kg
. Anaesthesia was maintained using oxygenxenon (MAC:71%) or oxygen-sevoflurane (MAC:2%) at an end-tidal concentration equal to 0.8 MAC (i.e. 57% xenon and 1.6% sevoflurane). Mean time from administration of vecuronium to 25% recovery of the first twitch of the train-offour response was significantly shorter in the xenon group than in the sevoflurane group (12.9 (SD 2.5) min vs 19.4 (6.0) min, respectively). Plasma concentrations of vecuronium at 25% recovery were significantly higher during xenon than during sevoflurane anaesthesia (187 (49) ng ml Xenon and sevoflurane are inhaled anaesthetics with a low blood-gas solubility coefficient which have been used in conjuction with neuromuscular blocking agents during clinical anaesthesia.
1 Potent inhalation anaesthetics variably influence the neuromuscular blocking effects of neuromuscular blocking agents, and sevoflurane has been evaluated in this respect. 2 However, the neuromuscular blocking effects of xenon have never been evaluated. To characterize the interaction between xenon and nondepolarizing neuromuscular blocking agents, we studied the onset and duration of vecuroniuminduced neuromuscular block, and plasma concentrations of vecuronium and 3-desacetylvecuronium under equianaesthetic concentration of xenon and sevoflurane anaesthesia.
Methods and results
After obtaining approval from the Institutional Human Studies Committee of Teikyo University and informed consent, we studied 27 ASA I-II adult patients undergoing elective general, orthopaedic, gynaecological or ENT surgery. No patient had neuromuscular, renal or hepatic disorders or was receiving any medication that might alter neuromuscular transmission. Patients were allocated randomly to one of two groups; 12 patients received xenon and 15 received sevoflurane anaesthesia. 3 No patient was premedicated. In the operating room, standard monitoring (electrocardiogram, pulse oximetry and non-invasive arterial pressure) was commenced. Arterial pressure was measured at 5-min intervals with a cuff positioned on the right arm. Lactated Ringer's solution was infused slowly via an i.v. cannula inserted in the left antecubital fossa. After induction of anaesthesia with fentanyl 0.5-1.0 g kg 91 and propofol 2-6 mg kg
91
, the trachea was intubated without neuromuscular blocking agents. Anaesthesia was maintained with oxygenxenon (MAC:71% 4 ) or oxygen-sevoflurane (MAC :2%) at an end-tidal concentration equal to 0.8 MAC (i.e. 57% xenon and 1.6% sevoflurane). Xenon concentration was monitored continuously at the Y connector with an AZ720 Xenon Monitor (Anzai Medical, Tokyo, Japan) and sevoflurane with an Ultima (Datex, Helsinki, Finland). There is no report in the literature demonstrating intraoperative awareness during anaesthesia with approximately 60% xenon. Even 30% xenon is known to suppress the stress response to noxious stimuli because of its analgesic effects. 5 Thus the concentration of xenon used in this study was expected to provide an adequate level of anaesthesia. A low-flow technique was used for xenon anaesthesia. The lungs were ventilated mechanically to maintain end-tidal carbon dioxide concentration at 4.0-4.7 kPa (Datex Ultima, Helsinki, Finland). Core temperature was maintained at 35.5-37.0ЊC using warming blankets. The right radial artery was cannulated at the wrist with a 22-gauge cannula and flushed with heparin for blood sampling.
Neuromuscular block was monitored with an accelerometer (TOF-guard; Biometer International, Odense, Denmark). Both arms were extended and the hands were fixed in supination beside the patient with the left thumb allowed to move freely. An accelerometer was attached via silver-silver chloride electrodes over the position of the ulnar nerve at the left wrist. The supramaximal current was determined using the automatic set-up procedure of the TOF-guard. This uses a current of 1 Hz which tests initially the electrode connections at 20 mA and then increases the stimula- tion to 60 mA. Twitch height is adjusted to 100% and the stimulation current is decreased automatically until twitch height starts to decrease. The current corresponding to this decrease is stored and the stimulation current returned to 60 mA. When the supramaximal stimulus had been determined, the stimulator continued to stimulate the ulnar nerve with a train-offour (TOF) pattern at 15-s intervals. When the response to TOF stimulation was stable, the magnitude of the first twitch of the train was taken as control twitch height. The end-tidal anaesthetic concentration and twitch response were stable for 45 min before administration of vecuronium. All neuromuscular responses were based on the first twitch of the TOF (twitch response). Approximately 60 min after induction of anaesthesia, vecuronium 0.05 mg kg 91 was given i.v. When the twitch response had recovered to 25%, 10 ml of blood were obtained via the arterial cannula for measurement of vecuronium concentration. Onset time was defined as the time from the beginning of administration of vecuronium to 90% depression of the first twitch of the TOF response. Duration of action was defined as the time from the beginning of administration of vecuronium to 25% recovery of the first twitch response. During the study, we monitored clinical signs of potential intraoperative wakefulness, such as lacrimation, sweating and tachycardia. Increases in arterial pressure of more than 20% of baseline were treated immediately with incremental doses of fentanyl 50 g i.v. On the day after surgery, all the patients were asked if they recalled any perioperative event or felt pain or discomfort during the study.
Blood samples were centrifuged promptly and the plasma removed. Plasma was buffered with NaH 2 PO 4 , frozen and stored at 935ЊC for subsequent measurement of concentrations of vecuronium and 3-desacetylvecuronium using gas chromatography 6 . The assay has a sensitivity of 5 ng ml 91 and a coefficient of variance of 15% at 10 ng ml 91 . All numerical data were analysed using unpaired t tests.
3 P:0.05 was considered statistically significant. All values are reported as mean (SD).
There were no significant differences between patient data or doses of propofol and fentanyl in the two groups. All patients achieved at least 90% twitch depression. Duration of action of vecuronium was 25% shorter in the xenon compared with the sevoflurane group (table 1) . No patient in either group showed clinical signs of potential intraoperative wakefulness or recalled intraoperative events when interviewed after operation.
We obtained blood samples from 24 patients; we failed to obtain blood samples from three patients in the sevoflurane group because of our inability to cannulate the right radial artery. Plasma vecuronium concentrations were 40% higher during xenon anaesthesia at 25% recovery of the first twitch of the TOF.
Comment
Our findings on the duration of action of vecuronium 0.05 mg kg 91 are consistent with previous studies which showed that potent inhalation anaesthetics variably influence non-depolarizing neuromuscular blocking agents, 2 although no direct comparison had been made between xenon and sevoflurane. Our study demonstrated that xenon had a lesser effect on recovery from vecuronium-induced neuromuscular block than sevoflurane.
The similar onset times of vecuronium in the xenon and sevoflurane groups may appear to conflict with their different durations of action. Although the exact mechanism of this similarity was not determined in our study, small doses (0.8 MAC) of inhaled anaesthetics and the small sample sizes could explain the lack of difference in onset time between the two anaesthetic groups.
Plasma concentrations of vecuronium were 40% higher during xenon compared with sevoflurane anaesthesia at similar levels of recovery from block. Assuming that plasma concentrations of vecuronium and 3-desacetylvecuronium reflect those at the neuromuscular junction, this suggests that xenon produces a smaller neuromuscular blocking effect than sevoflurane. However, in our study vecuronium was administered as a bolus, not as a continuous infusion, in order to duplicate our clinical practice. This design did not achieve steady state plasma vecuronium concentrations and may be criticized because of the possible lack of equilibration between the plasma and neuromuscular junction. Therefore, plasma concentrations of vecuronium and 3-desacetylvecuronium in our study may not have reflected concentrations at the neuromuscular junction at that time. We provide only suggestive, but not conclusive, evidence that xenon has lesser pharmacodynamic effects than sevoflurane. 
